Blog - etira

Breakthroughs that
make news.

See news releases about Etira, our stellar team,
our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.

ERX-315 CLINICAL TRIAL APPROVED BY HREC

Dallas, TX – August 1, 2024: Etira is pleased to announce the approval of the ERX-315 Phase 1 clinical trial by the Australian Human Research Ethics Committee (HREC). This HREC approval enables the start of the clinical trial titled "A Phase…

Etira’s Australian partner MMIC expands

News

Melbourne, Australia - July 10, 2024: The expansion of Etira partner Medicines Manufacturing Innovation Centre (MMIC) to the Monash Technology Precinct in Clayton was highlighted in the press. This expansion will enable further opportunities…

DECRYPTING THE OLIGO-BENZAMIDE PLATFORM

News

Dallas, TX – June 15, 2024: The laboratory of Etira founder Dr Jung-Mo Ahn presents a comprehensive overview of the oligo-benzamide platform that emulates a-helical peptide segments in proteins and disrupts protein-protein interactions. Herein,…

ERX-315 SUBMITTED FOR HREC APPROVAL

News

Dallas, TX – May 14th, 2024: Etira is pleased to announce the submission of the regulatory documents for approval of administration of its breakthrough oncology drug ERX-315 to the Human Research Ethics Committee (HREC) in Australia. This…

ERX-208 potency in Ovarian Cancer

News

San Diego, CA. April 10, 2024: Etira founder Dr Ratna Vadlamudi’s laboratory presents comprehensive data on the activity of ERX-208 in ovarian cancer. ERX-208 is active against all four molecular subtypes of ovarian cancer and its activity…

Targeting LIPA in ovarian cancer

News

Dallas, TX. January 24, 2024: We are pleased to present a manuscript in Cancers from the laboratory of Etira founder Dr. Ratna Vadlamudi. The data presented show that ERX-41 targets LIPA in ovarian cancer and is effective against all 4 subtypes…

Breakthroughs thatmake news.

See news releases about Etira, our stellar team,our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.

Where to find us

Breakthroughs that
make news.

See news releases about Etira, our stellar team,
our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.